Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Negri

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|October 12, 2013
Discovery of novel bacterial RNA polymerase inhibitors: pharmacophore-based virtual screening and hit optimizationStefan Hinsberger, Kristina Hüsecken, Matthias Groh, et al.
ACS Chemical Biology|January 22, 2013
Peptide-based investigation of the Escherichia coli RNA polymerase σ(70):core interface as target siteKristina Hüsecken, Matthias Negri, Martina Fruth, et al.
BMC Biophysics|August 7, 2013
Molecular basis of HHQ biosynthesis: molecular dynamics simulations, enzyme kinetic and surface plasmon resonance studiesAnke Steinbach, Christine K Maurer, Elisabeth Weidel, et al.
Journal of Medicinal Chemistry|February 1, 2013
Modulation of cytochromes P450 with xanthone-based molecules: from aromatase to aldosterone synthase and steroid 11β-hydroxylase inhibitionSilvia Gobbi, Qingzhong Hu, Matthias Negri, et al.
Journal of Molecular Modeling|May 21, 2014
Mechanistic details for anthraniloyl transfer in PqsD: the initial step in HHQ biosynthesisMichael C Hutter, Christian Brengel, Matthias Negri, et al.
Journal of Medicinal Chemistry|August 5, 2008
Synthesis, biological evaluation, and molecular modeling of abiraterone analogues: novel CYP17 inhibitors for the treatment of prostate cancerMariano A E Pinto-Bazurco Mendieta, Matthias Negri, Carsten Jagusch, et al.
European Journal of Medicinal Chemistry|February 13, 2009
Novel CYP17 inhibitors: synthesis, biological evaluation, structure-activity relationships and modelling of methoxy- and hydroxy-substituted methyleneimidazolyl biphenylsUlrike E Hille, Qingzhong Hu, Carsten Vock, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 27, 2020
Homology modeling meets site-directed mutagenesis: An ideal combination to elucidate the topology of 17β-HSD2Christoph P Sager, Susanne Weber, Matthias Negri, et al.
Journal of Medicinal Chemistry|September 4, 2008
Novel aldosterone synthase inhibitors with extended carbocyclic skeleton by a combined ligand-based and structure-based drug design approachSimon Lucas, Ralf Heim, Matthias Negri, et al.
Bioorganic & Medicinal Chemistry|April 24, 2010
Novel estrone mimetics with high 17beta-HSD1 inhibitory activityAlexander Oster, Tobias Klein, Ruth Werth, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|October 12, 2013
Discovery of novel bacterial RNA polymerase inhibitors: pharmacophore-based virtual screening and hit optimizationStefan Hinsberger, Kristina Hüsecken, Matthias Groh, et al.
ACS Chemical Biology|January 22, 2013
Peptide-based investigation of the Escherichia coli RNA polymerase σ(70):core interface as target siteKristina Hüsecken, Matthias Negri, Martina Fruth, et al.
BMC Biophysics|August 7, 2013
Molecular basis of HHQ biosynthesis: molecular dynamics simulations, enzyme kinetic and surface plasmon resonance studiesAnke Steinbach, Christine K Maurer, Elisabeth Weidel, et al.
Journal of Medicinal Chemistry|February 1, 2013
Modulation of cytochromes P450 with xanthone-based molecules: from aromatase to aldosterone synthase and steroid 11β-hydroxylase inhibitionSilvia Gobbi, Qingzhong Hu, Matthias Negri, et al.
Journal of Molecular Modeling|May 21, 2014
Mechanistic details for anthraniloyl transfer in PqsD: the initial step in HHQ biosynthesisMichael C Hutter, Christian Brengel, Matthias Negri, et al.
Journal of Medicinal Chemistry|August 5, 2008
Synthesis, biological evaluation, and molecular modeling of abiraterone analogues: novel CYP17 inhibitors for the treatment of prostate cancerMariano A E Pinto-Bazurco Mendieta, Matthias Negri, Carsten Jagusch, et al.
European Journal of Medicinal Chemistry|February 13, 2009
Novel CYP17 inhibitors: synthesis, biological evaluation, structure-activity relationships and modelling of methoxy- and hydroxy-substituted methyleneimidazolyl biphenylsUlrike E Hille, Qingzhong Hu, Carsten Vock, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 27, 2020
Homology modeling meets site-directed mutagenesis: An ideal combination to elucidate the topology of 17β-HSD2Christoph P Sager, Susanne Weber, Matthias Negri, et al.
Journal of Medicinal Chemistry|September 4, 2008
Novel aldosterone synthase inhibitors with extended carbocyclic skeleton by a combined ligand-based and structure-based drug design approachSimon Lucas, Ralf Heim, Matthias Negri, et al.
Bioorganic & Medicinal Chemistry|April 24, 2010
Novel estrone mimetics with high 17beta-HSD1 inhibitory activityAlexander Oster, Tobias Klein, Ruth Werth, et al.
Pageof 4